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Abstract 
 
Introduction: 
 Alcoholism and related complications are more prevalent world wide.  
Alcohol use is associated with more than 60 medical conditions.  Alcohol use 
disorders (AUD) generally confirmed by screening test based on questionnaires 
like AUDIT.  Mean Corpuscular Volume also elevated in alcohol use 
disorders.  Aim of this study is to evaluate usefulness of MCV as a marker of 
AUD.   
Methods: 
 Totally 100 patients were evaluated.  Patients who were admitted in 
medical wards of Rajiv Gandhi Government General Hospital, Chennai for 
found to having alcohol use disorders by AUDIT.  Patients history were taken 
as per the questionnaire and patients were subjected to clinical examinations.  
Investigations like Complete Blood Count, Peripheral smear,  Random Blood 
Sugar, Blood Urea, Serum Creatinine, Liver Function Test, Thyroid 
Stimulating Hormone Assay (TSH), USG abdomen also done and results were 
analysed.   
 
 
 
Results: 
 Out of 100 patients with AUD, 61 patients had elevated MCV of >100 
with statistically significant p value 0.028.  62 patients had elevated AST/ALT 
ratio of >1.  To confirm this findings, large community based trails needed in 
persons with AUD without other medical comorbidity.   
Key words: 
AUDIT, AUD, MCV 
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INTRODUCTION 
The intake of more than 3 standard drinks per day on continuously 
enhances the possibility of malignancy and vascular disease, and alcohol 
consumption in excess decrease the life span by about 10 years.  
Alcohol distributes throughout the body, affecting almost all organs 
and altering nearly every neuro chemical process in the brain. Alcohol is 
likely to exacerbate most medical conditions, temporarily mimic many 
medical and psychiatric conditions.  
In Western countries 80 percent of adult populations have drunk 
alcohol, and two-thirds have been drunk in the last year, the lifetime risk for 
serious, recurring alcohol problems is almost 20% for men and 10% for 
women, irrespective of a person's educational status or income. 
Global scenario  
Over all 3.5% of worldwide prevalence was caused by drinking 
alcohol, causing as much  mortality and morbidity compared to tobacco and 
high blood pressure
3,4
.  Alcohol consumption is causally related to more 
than 60 clinical conditions
5
. 
There is a rapid increase in per capita consumption of alcohol 
between1980and 2000 by over 50%.  The fastest growth has been in the 
Asian countries
6. 
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45% of total recorded alcohol is consumed in the form of spirits.  
36% from beer, remaining contributed by wine and other beverages.  
Overall high alcohol consumption noted in the Russian Federation 
countries. 
Trends in adult per capita consumption   
 Five year trend in alcohol consumption from 2001 to 2005 shows that 
there was a increase in alcohol consumption in developing countries.  There 
was 68.3% increase in South East Asian countries and increase by 25.3% in 
African countries.  The world wide increase in alcohol consumption noted 
was 23.5%.   
Alcohol consumption among young people 
 Global survey on health and alcohol conducted by WHO in 2008 
shows that there was 71% increase in “underage drinking”.  Among 18 – 25 
year old, there was 80% increase in alcohol consumption.   
Alcohol rated mortality 
42% alcohol attributable deaths were due to injuries.  It was most 
commonly occurred during alcohol intoxication.  Alcohol attributable 
mortality and disease burden per pure litre of alcohol consumption was 
more for underdeveloped and developing countries.      
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Figure 1 : Consumption of Alcohol in litres per capita – 2005 
 
 
 
Indian scenario 
The per capita  intake  of ethanol by an Indian adult aged more than 
15 years augmented by more than 100%between two decades
7
.  The 
drinking pattern also altered from occasional use to frequent use.   Recently, 
these expansions have raised up worries about the medical and the 
communal significances of too much alcohol intake
8
. 
As per Government statistics, 21% of adult men and 2% adult women 
consumes alcohol.  Among them, 20% were alcohol dependent who require 
management
35
.   
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“Average age of initiation” of alcohol dropped from 19 years to13 
years in last 20 years
35
.  The fraction of people taking below 21 years has 
enlarged from 2% to 14% in the last 15 years.   
More than 20% of hospital admissions, 18% of psychiatric 
emergencies and 60% of all injuries, 20% brain injuries who were attending 
hospital casualty rooms were related to alcohol
35
.  Alcohol contributes to 
domestic violence.  One third of domestic violence were related to alcohol 
intake.      
Indians preferred to drink distilled alcohol more than wine and beer 
which contains higher level of pure alcohol (30 – 50%) leads to more 
complications.   
Beverage preference in India 
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AIMS AND OBJECTIVES 
 
 To evaluate the usefulness of mean corpuscular volume to identify 
alcohol use disorder in comparison with AUDIT (Alcohol Use 
Disorders Identification Test) screening test.   
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REVIEW OF LITERATURE 
Alcohol not only affects the person who consumes it, also affects his 
or her family and society.  Alcoholism mainly affects the persons of 
productive age group, it also related to drug abused, high risk sexual 
behavior, anti social activities.  It affects the person irrespective of 
education and income.  Alcoholism related complications are major threat to 
our country.  Changing drinking pattern from occasional to social and 
acceptance of a drinking as a normal phenomenon, young drinkers all are 
major concern to our society.   
Prevalence of alcoholism in rural Tamil Nadu shows that prevalence 
of alcohol use in adult male is 16.8% and in female it is 1.3%
42
.     
Types of Alcoholic Beverages 
There are a more varieties of alcoholic drinks. 
A. Malted liquors Acquired by fermentation of cereals; which are 
undistilled —  alcohol content in them lies between 3-6% e.g. Beers, Stout. 
Now beers with the strength  up to 10%) are also produced. 
B. Wines Manufactured by fermentation of sugars existing mainly 
fruits like grapes and fruits.  Wines are undistilled.  When the amount of 
alcohol is 9-12%, they are called Light wines e.g., Cider is 9–12%, alcohol 
content cannot surpass 15%.  When the distilled alcohol is added Fortified 
wines are made e.g., Sherry (alcohol 16–22%):   
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When bottled before fermentation of wines Champagne (12–16% 
alcohol) are made.  Dry wine made from fermentation all sugars present in 
the wine and sweet wine made if when little sugar present.  
C. Spirits These are produced by distillation after fermentation e.g. 
Rum, Brandy, Vodka and others.  The amount of alcohol present in them is 
between 40–55%, in our country (and almost worldwide) 42.8% v/v or 37% 
w/w is standard accepted   percentage worldwide for common brands. 
  The taste, aroma depends not only on alcohol content but on the 
availability of excess ethers, amount of aldehydes, esters, polymers, and 
volatile oils; most of them are produced during ‘maturation’ of the alcohol.  
Other forms of alcohol 
1.       Dehydration alcohol  produces- Absolute alcohol 99% w/w 
ethanol  
2.  From molasses by distillation produces Rectified spirit 90% w/w 
ethanol 
3. Proof spirit made when whisky is drizzled on gun powder and burned 
and it blowup, then it was branded to be of ‘proof strength’. If water 
is mixed to it, gun powder will not ignite.  
Standard drinks. 
In worldwide varies countries, health educators and investigators 
apply varies definitions of one standard drink because of differences in the 
usual serving amounts in that nation. For e.g., 1 unit of drink in Canada: 
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13.6 g of pure alcohol.  1 standard drink in the England: 8 g 1 s drink in the 
America: 14 g one standard drink in Australian continent:  the AUDIT, 
Questions 2 and 3 accept that a “standard drink equivalent is 10 grams” 
of alcohol. The recommended low-risk consumption level set in the brief 
intervention  manual and used in the WHO study  interventions is not excess 
than twenty grams of alcohol per day, two days abstinence. 
Calculation for the amount of Alcohol in a beverage 
Amount of alcohol present in a drink depends on the strength of the 
drink and the content of the container.  There are large differences in the 
strengths of alcoholic drinks and the drink sizes in different nations.  A 
WHO survey  showed that beer contains between 2%and 5%  pure alcohol  
10.5%to 18.9%  in wines.  In distilled spirits it is varied between24.3% to 
90%, and in cider it is from1.1% to 17%. Hence, it is important to adjust 
drinking amounts to what is most prevalent at the native level and to 
recognize approximately the amount pure alcohol the individual drinks per 
time and on average. 
Additional concern is calculating the volume of alcohol contained in a 
standard drink is the conversion factor of ethanol. That permits you to 
transform any amount of alcohol into gms. 
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For each ml of ethanol, there are 0.79 gms of pure ethanol.  For (e.g.) 
beer of (330 ml at 5% x(strength) 0.79 (conversion factor) = 13 gm  ethanol 
one glass wine (140 ml) at 12% x 0.79 = 13.3 grammes of ethanol one shot 
spirits (40 ml) at 40% x 0.79 = 12.6 gms of ethanol. 
METABOLISM OF ALCOHOL 
Alcohols are hydroxy product of aliphatic hydrocarbons.  When 
complete, ‘alcohol’ means to ethyl alcohol or ethanol.  Pharmacology of 
alcohol is significant for its presence in a drink (which have been used from 
the time olden days) and for liquor intoxication, rather than as a drug.   
Alcohol is mass-produced by fermentation of sugars: Zymase C6H12O6 
2CO2 + 2C2H5OH (in yeast) Fermentation continues till alcohol percentage  
reaches ~ 15%. Then the reaction is stopped by ethanol itself.  
STARCH MALTOSE 
.  The fermentation cereal by yeast produces alcohol.  Important 
source of  available  alcohols is mollases, a co product of sugar production.    
The most part of ethanol is metabolized mainly in the liver between 2% to 
10% of ethanol is expelled straight through the lungs and also excreted 
through urine, or sweat.  There are two pathways for alcohol metabolism 
one at cytosol and other one at microsomes of the smooth endoplasmic 
reticulum. 
Acetaldehyde produced by action of cytosolic alcohol dehydrogenase 
(ADH).  By aldehyde dehydrogenase (ALDH) rapidly converts in to other 
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metabolite in the cytoplasm as well mitochondria.  Another pathway is in 
the microsome (the microsomal ethanol-oxidizing system or MEOS 
accountable for oxidative metabolism of ethanol). 
 
Pharmacology and Nutritional Impact of Ethanol 
Blood levels of alcohol are represented as mg or gm of ethanol per/dl.  
Alcoholic beverages also contains additional components known as 
congeners that affect taste of the drink and might contribute to adverse 
reactions on the body.  Congeners include methanol, butanol, acetaldehyde, 
histamine, tannins, iron, and lead.  
The higher the alcoholic content of the beverage, higher is the blood 
alcohol concentration (BAC). Alcohol is absorbed largely from the initial 
parts of the small intestine, although moderate amounts are absorbed from 
the stomach and proximal large bowl, and little amounts from the mucous 
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membranes of the mouth and oesophagus factors affecting blood alcohol 
concentration. 
Drinking on an empty stomach, gulping drinks, mixing carbonated 
drinks, such as soda along with the alcohol, all enhance absorption. 
Presence of fats, proteins and carbohydrates in the diet, presence of 
congeners can slow down absorption. Congeners found in alcoholic 
beverages, especially illicitly brewed alcohol (such as methanol, butanol, 
aldehydes, esters, histamines, phenols, tannins and heavy metals such as 
iron, lead and cobalt) can contribute to organ damage. 
Blood alcohol peaks 30 to 60 minutes after consumption on an empty 
stomach.  Women having higher fat content than men so they achieve higher 
blood alcohol for the same dose of alcohol. 
INTERACTIONS 
1. Alcohol synergises with anxiolytics, antidepressants, antihistaminics, 
hypnotics, opioids →marked CNS depression with defective motor   
function can occur: Probabilities of accidents in and injuries elevated 
many fold. 
 
2. Persons taking anti diabetic drugs  like sulfonylureas especially   
(chlor probamide not available in India), certain antibiotics like 
cephalosporins (cefoperazone, moxalactam, cefamandole) and 
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metronidazole  have  developed  annormal, somewhat disulfiram-like  
adverse reactions when they drink alcohol. 
3. Acute  excess alcohol consumption inhibits, while prolnged intake 
induces metabolism of many drugs like  anti diabetic drug 
tolbutamide, and anti epileptics like  phenytoin and many other drugs 
4. Interaction with insulin and sulfonylureas - these drugs are known to 
cause hypoglycemia by excess insulin.  Alcohol reduces hepatic 
glycogen content when the alcoholics takes the medication risk of 
hypoglycemia increased many fold. 
5. Alcoholics more prone to develop alcoholic gastritis and upper 
gastrointestinal bleeding when consumed in excess amount.   
NSAIDS like diclofenac which was commonly used as pain killer and 
antiplatelet like aspirin and steroids increases the risk of bleeding. 
6.  Paracetamol is known to cause liver damage. Alcoholics have 
reduced glutathione reserve so they more prone for paracetamol 
induced liver toxicity. However in patient with cirrhosis up to two 
gram of paracetamol can be given if medical condition needed it. 
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Tolerance to alcohol 
Can occur due to three different mechanism: 
 metabolic or pharmacokinetic tolerance occurs, after 1–2 weeks of 
daily alcohol consumption,  it is due to accelerated in the rate of 
ethanol metabolism in the hepatic tissue. This change goes almost 
as quickly as it progresses. 
 Cellular or pharmacodynamics tolerance occurs due to
neurochemical changes that relatively maintains normal
physiologic functioning inspite of the presence of alcohol. When 
three is decreases in blood levels leads on to development of with 
drawl symptoms.  
 In third type of tolerance (learned or behavioural tolerance).
Individuals function better than expected under influence of the 
alcohol. 
The Effects of Ethanol  in the varies body Systems
44 
          Alcohol affects almost all the organ systems in the body.  It 
associated with around 60 known medical conditions.   
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Nervous System 
         Roughly 35% of alcoholics had an episode of temporary anterograde 
memory loss, in which the individual forgets all or part of events that 
happened during a drinking period that is called as blackout.  
         Disturbed sleep is an another common problem, alcohol may help a 
person to fall asleep initially, but it disrupts sleep all over the rest of the 
sleep  by altering the  varies stages of sleep and  hours spent in rapid eye 
movement (REM) and deep sleep is reduced excess snoring and exacerbate 
sleep apnoea occurs in alcoholics due to relaxation of muscles in the 
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pharynx of alcoholics may also experiences disturbing dreams. Sleep 
related problems are more marked in alcoholics, and their persistence may 
lead on to relapse. 
          Impaired judgment and coordination are common consequence of 
alcohol use, increases the risk of accidents and injury.  In the United States, 
excessive alcohol consumption can also be associated with headache, 
polydipsia, nausea, vomiting, and excessive tiredness the following day, it 
is called as hangover syndrome .that is responsible for much missed time 
and temporary cognitive impairment at workplace. 
          Chronic excess alcohol doses cause peripheral neuropathy in 10% of 
alcoholic patients clinically presented as bilateral limb numbness which is 
more pronounced distally, tingling, and paraesthesia.  Approximately 1% of 
chronic alcoholics develop cerebellar degeneration or atrophy. This 
syndrome characterised by advanced imbalance in stance and gait often 
associated nystagmus.   MRI brain studies shows atrophic changes in the
cerebellar vermis.  
         Wernicke’s (ophthalmoparesis, ataxia, and encephalopathy) and 
Korsakoff's (retrograde and anterograde amnesia) syndromes are rare 
occurs 1 in 500 alcoholics.  These syndromes occur as the result of reduced 
levels of thiamine. 
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         Decreased Brain volume, evident as ventricular enlargement and 
widened cortical sulci on neuro imaging, occurs in fifty% of chronic 
alcohol drinkers; these changes are usually normalise if abstinence is 
continued for years.  
Psychiatric problems  
        As for Diagnostic and Statistical Manual of Mental Disorders (DSM-
IV) two-thirds of alcohol-dependent individuals meet the criteria for a 
psychiatric syndrome. 
        50% of these relate to a underlying antisocial personality manifesting 
as impulsive behavior and loss inhibition that contribute to both alcohol and 
drug dependence. 
         Others have psychiatric syndromes have psychiatric conditions such 
as schizophrenia or mania or depression disease and anxiety disorders such 
as panic disorder. Many psychiatric syndromes can be seen in the short 
term during excess alcohol intake and followed by withdrawal.  
Alcohol-induced mood disorder 
          These alcohol-induced mood  disorder include an marked low mood
lasting for days to weeks in the midst of excess drinking  documented 
in 40% of alcoholics, it will take several weeks to  resolving of symptoms  
after  stopping alcohol. 
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Alcohol-induced anxiety disorder 
          Profound anxiety occurs in 10–30% of alcohol drinkers temporarily. 
Usually starts at the time alcohol withdrawal, which may persist for a 
month or more after stopping of alcohol ingestion.  
alcohol-induced psychotic disorder 
          Auditory hallucinations and/or paranoid delusions in a person who is 
alert and oriented, seen in 3–5% of alcoholics.  Alcohol-induced conditions 
are temporary and usually does not need long-term pharmaco therapy, any 
patient who has above mentioned psychiatric symptoms history of 
excessive alcohol use is an important part of the workup . 
The Gastrointestinal System 
Esophagus and Stomach 
          Excess Alcohol ingestion can cause marked inflammation of the 
upper gastero intestional tract mainly esophagus and stomach causing 
epigastric discomfort and upper gastrointestinal bleeding.  Haemorrhagic 
gastritis is Commonly caused by excess Alcohol consumption.  Forceful 
vomiting after alcohol ingestion can produce severe bleeding through a 
Mallory-Weiss tear, a longitudinal tear in the mucosal layer of 
gastroesophageal junction. 
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Pancreas  
           Alcoholic develops acute pancreatitis almost three times higher than 
the general population, contributed to 10% or more of the total cases. 
Liver 
          Long term alcohol intake can leads on to  spectrum of liver pathology 
that varies  from mild fatty liver to cirrhosis and HCC( hepatocellular 
carcinoma). Fat accumulation in liver cells is seen in 90% of alcoholic  fatty 
change is most predictable and earliest response to alcohol ingestion. 
impaired glucose production ,in the liver, resultant in a fall in the quantity
of glucose made from glycogen, reduced oxidation of fatty acids and 
increased lactate production, in alcoholics leads onto an increase in fat 
accumulation in hepatic cells causes fatty liver. 
          Risk factors for development of alcohol related liver disease includes
gender, associated hepatitis c infection, poor nutrition, heritable and the 
Amount of alcohol ingested. Type of alcohol usually not related to
alcoholic liver disease, female are more prone to develop with less quantity, 
high fat intake predispose and coffee intake has productive effect. 
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Spectrum of Alcoholic Liver Diseases 
 
           10% of people will develop cirrhosis if they continuous drink 
heavily.  Patients with both micro- and macro vesicular pattern of steatosis 
having more risk of developing cirrhosis than patients with only the macro 
vesicular
2
.  About 10to35% of heavy drinkers will develops alcoholic
hepatitis it is a prerunner of cirrhosis associated with high short term 
mortality. Continued alcohol ingestion, causes (micro nodular, or 
Laennec's, cirrhosis) in 8% to 20% of excess alcohol consumper.  Over 
time, and especially with long term abstinence from alcohol, this changes
can evolves into (macro nodular cirrhosis). 
          In patients who have had complications of cirrhosis and who continue 
to take alcohol, 5 year survival rate reduced to50%.
l   
In contrast, in those 
patients who are able to remain abstinent, the prognosis is significantly 
improved.
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          Alcoholics have an increased rate of hepatitis C infection, and excess 
alcohol consumption in the setting of hepatitis c infection more severe liver 
deterioration will occur. 
Cancer 
          Alcohol promotes cancer by direct effects of alcohol and 
acetaldehyde.  And another mechanism is by altered immune homeostasis.
As low as 1.5 drinks per day increases risk of carcinoma breast in a female
by1.4-fold.  For both males and females, four drinks per day elevate the risk 
for oral and oesophageal malignancy threefold and rectal cancers 1.5 fold; 
seven to eight or more drinks per day increases approximately five times
the risks for so many malignancies.  
Hematopoietic System 
          Excess alcohol intake causes an increase in red blood cell size [mean 
corpuscular volume (MCV)], by affecting stem cells. If heavy drinking is 
associated with by folic acid deficiency, along with increased red blood cell 
size, hyper segmented neutrophils, reticulocytopenia, and a hyperplastic 
bone marrow will also present.  If alcohol intake associated with 
malnutrition sideroblastic changes can also be observed.  White blood cell 
production decreased in Chronic alcoholics.  It also affect granulocyte 
mobility and adherence, and false-negative tuberculin skin test occurs 
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because of impaired delayed-hypersensitivity responses to antigens. 
Hepatitis and HIV infection risk is higher than in general population due to 
associated immune deficiency and altered liver function interfere with 
treatment. Mild thrombocytopenia common in alcoholics usually it resolves
within a week after cessation of alcohol. When it does not resolve we have 
to rule out cirrhosis of liver or congestive splenomegaly. 
Cardiovascular System 
          Acute alcohol consumption causes peripheral vasodilation and it 
decreases myocardial contractility, resulted in mild reduction in blood 
pressure and also compensatory rise in cardiac output.  Cardiac oxygen 
consumption during exercise is higher after alcohol consumption.  When 
the patient having underlying cardiac disease these changes can affect 
damaged heart. 
           There will be a dose-dependent increase in blood pressure will 
occurs, then the patient drinks of three or more drinks per day. Blood
pressure will be normalized after cessation of alcohol.  Thus, excess alcohol 
consumption is an important risk factor for mild to moderate hypertension.  
risk for coronary artery disease is six times higher for chronic excessive 
drinker, may related to increased low-density lipoprotein cholesterol. 
Alcohol directly affects cardiac muscle and causes cardio myopathy.  
Unexplained arrhythmias, cardiac  failure, hypo contractility of cardiac 
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muscle, and dilation of both ventricle and atrium lead on mitral 
regurgitation and formation of mural thrombi all will occur because of 
excess alcohol.  Holiday heart syndrome characterized by paroxysmal 
tachycardia in a structurally normal heart after excess alcohol consumption 
it is due to Atrial or ventricular arrhythmias.  It normalize after cessation of 
alcohol 
Genitourinary System 
           Excess alcohol consumption in teen age boys and girls can affect 
normal sexual development and reproductive onset.  Although alcohol in 
moderation increases the sexual drive but it causes impaired erectile 
function in men. Even in the absence of hepatic impairment.  Permanent 
loss of testicular volume with atrophy of the semniferous tubules, decreases 
in seminal volume as well as low sperm count will occur in chronic alcohol 
drinker. 
         The continuous ingestion of high doses of alcohol by the women who 
consumes large doses alcohol will develop amenorrhea, reduction in
ovarian size, corpora lutea will become absent and they become infertile.
When they become pregnant there is an increased risk of spontaneous 
abortion. Excessive drinking during ante natal period results in fetal alcohol 
syndrome (FAS), it is due to rapid transfer of alcohol and its product 
acetaldehyde, through placenta to the fetus.  Milder form this condition is 
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called fetal alcohol spectrum disorder (FASD).  Not even a little amount of 
alcohol is safe during pregnancy, there is no specific cut off for safe 
drinking during pregnancy period.  Alcohol should be avoided completely. 
         Fetal alcohol syndrome (FAS) characterized by facial dimorphism 
such as microcephaly, epicanthal eye folds; poorly formed ears; small teeth 
with defective enamel; cardiac anomalies in the form of septal defects; an 
unusual palmar crease and restriction in joint movements; and with mental 
retardation. 
          Fetal alcohol spectrum disorder (FASD) described by decreased 
birth weight, a low IQ, and hyperactive behavior, and mild cognitive 
impairment.  
          Acute alcoholic myopathy can occurs   alcoholics characterized by 
skeletal muscle weakness that partially improved after abstinence caused by
osteoporosis and osteo necrosis occurs in chronic alcoholic due to alteration 
in the calcium metabolism.  Effects of chronic excessive drinking on the 
skeletal system comprise of changes in calcium metabolism, and decreased 
bone mineral density, and reduced rate of growth in the epiphyses, leads on 
to augmented risk fractures and osteonecrosis of the head of femur.  
Hormonal changes 
         In healthy individual transient hypoglycemia can occur following 
excessive alcohol consumption within 6–36 h, it is due to the actions of 
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alcohol on glucose formation by inhibiting gluconeogensis. This can result 
in transient abnormality in glucose tolerance tests (with a resulting wrong 
diagnosis of diabetes mellitus) until the alcoholic has abstained for 
minimum two weeks.  
          Alcohol ketoacidosis can occur because of reduction in fatty acid 
oxidation along with decreased intake or repeated vomiting can be wrongly 
diagnosed as diabetic ketoacidosis.  It can be differentiated by normal to 
mildly elevated blood sugar usually less than 250 mgs /dl in alcoholic keto 
acidosis. And by clinical feature like parotid swelling. 
         Cortisol levels are elevated in alcoholics, it correlated with excessive 
alcohol consumption.  Usually alcoholic are over hydrated because of 
inhibition of vasopressin secretion at increasing blood alcohol 
concentrations and increased secretion at falling blood alcohol 
concentrations.  So when treating alcohol intoxication intravenous fluids are 
not nessary unless dehydration is present. 
          Serum triiodothyronine (T3) level decrease more markedly in 
comparison with serum thyroxine (T4) which is decreased in modest 
amount.  Hormonal problems should be reassessed as they may disappear 
after a month of alcohol abstinence. 
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         Whenever a patient come for below mentioned problems, we have to 
think alcohol as attributing factor and further enquiries should be made. 
 Adult onset seizure 
 Young stroke 
 Poorly controlled hypertension 
 Young onset or poorly controlled diabetes 
 Hepatitis, cirrhosis 
 Peripheral neuropathy 
 Pancreatitis 
 Parotid gland enlargement 
 Cancer 
 Gastrointestinal symptoms of undermined cause 
 Sleep disturbances 
 Unexplained falls or accidents 
 Poorly controlled gout 
 Confusion or cognitive impairment 
 Non-specific somatic symptoms 
 Work-related problems such as absenteeism 
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Withdrawal Syndrome 
A withdrawal state is regarded as by a group of symptoms, often 
specific to the drug used, which follows on complete or partial withdrawal 
of a drug, generally after recurrent and/or high-dose use. This, too, is a 
short-lasting syndrome with usual duration of few hours to few days. 
Typically, the patient reports that the withdrawal symptoms are 
controlled by further substance use. The withdrawal state is further 
classified as: 
i. uncomplicated 
ii. with convulsions; and 
iii. with delirium 
Withdrawal Syndrome 
The most common withdrawal syndrome is a hangover on the next 
morning. Mild tremors, nausea, vomiting, weakness, irritability, insomnia 
and anxiety are the other common withdrawal symptoms. Sometimes the 
withdrawal syndrome may be more severe, characterized by one of the 
following three disturbances: delirium tremens, alcoholic seizures and 
alcoholic hallucinosis.  It is important to remember that alcohol withdrawal 
syndrome can be associated with marked morbidity as well as significant 
mortality, and it is important to treat it correctly.  
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Delirium tremens (DT) is the dangerous form of alcohol withdrawal 
syndrome. It comes about generally within 2-4 days of total or significant 
abstinence from excess alcohol drinking in about 5% of patients, as related 
to acute tremlousness which occurs in about 34%of patients. 
The course is brief, with improvement occurring within 3-7 days. 
This is an acute organic brain syndrome (delirium) with following clinical 
features: 
 
i. Impairment of consciousness with not oriented to time and place. 
ii. Lack of attention and easy distractibility. 
iii. Visual (and also auditory) hallucinations and illusions which are 
often vivid and very frightening. 
iv.  insects crawling  sensation over the body may occur called as 
Tactile hallucinations 
v.  Autonomic disturbance in the form increased pulse rate, fever, 
elevated blood pressure, sweating and pupillary dilatation. 
vi. Psychomotor agitation and ataxia.  
vii. Insomnia, with a reversal of sleep-wake pattern 
viii. Dehydration with electrolyte disturbance.  Death can occur in 5-
10% of patients with deliriumtremens and is often due to 
cardiovascular collapse, infection, hyperthermia or self-inflicted 
injury. At times, intercurrent medical illnesses such as pneumonia, 
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fractures, liver disease or pulmonary tuberculosis may complicate 
the clinical picture. 
2. Alcoholic seizures (‘rum fits’) 
Generalised tonic clonic seizures occur in about 10% of alcohol 
dependence patients, usually 12-48 hours after a heavy bout of drinking. 
Often these patients have been drinking alcohol in large amounts on a 
regular basis for many years. Multiple seizures (2-6 at one time) are more 
common than single seizures. Sometimes, status epileptics may be 
precipitated. In about 30% of the cases, delirium tremens follows. 
 
3. Alcoholic hallucinosis 
Alcoholic hallucinosis is characterized by the presence of 
hallucinations (usually auditory) during partial or complete abstinence, 
following regular alcohol intake. 
It occurs in about 2% of patients.  These hallucinations persist after 
the withdrawal syndrome is over, and classically occur in clear 
consciousness. 
Usually recovery occurs within one month and the duration is very 
rarely more than six month. 
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Alcohol dependence   - biopsychosocial disorder 
Biological Vulnerability 
          There have been many studies to support the heritable nature of alcoholism 
including family, twin and adoption studies, which indicate a four-fold increase 
in the risk for developing alcoholism in children of alcoholics. Studies suggest 
that the inherited risk for the development of alcohol dependence is 50% to 60%. 
          Neurotransmitter Changes after alcohol use Different neurotransmitters are 
also known to alter alcohol consumption behaviour.  Dopamine may contribute 
to the motivation and reinforcement of alcohol consumption. 
          Serotonin levels appear to be lower in the brains of alcohol dependents 
compared to non alcoholics. It may promote alcohol’s intoxicating and 
rewarding effects.  
          Glutamate receptors in the brain are inhibited by alcohol land this may 
account in part for the cognitive dysfunction that occurs with alcohol intake.  
Mediate the sedative effects of alcohol.  
          Alcohol-induced modifications in GABA receptor function may leads on 
to alcohol dependence and tolerance, and abnormalities in the GABA system 
may predispose to alcoholism. In addition, various neuromodulators affected by 
alcohol include endogenous opioid peptides (which may mediate alcohol 
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reinforcement and excessive alcohol consumption), adenosine(which may 
mediate many of alcohol’s acute and chronic effects on the CNS such as 
incoordination, intoxication and sedation) 
Psychosocial Theories 
          Social factors, such as broken families, single parent families, parental 
‘models’, peer pressure, availability of alcohol and cultural sanction of drinking, 
all contribute to the progress of alcohol abuse and dependence. 
          Psychological vulnerability, including stress full life situations, low self-
esteem, poor coping and low communication skills may predispose to 
alcoholism. Alcoholism has also been described as a learnt behaviour, with the 
temporary relief from anxiety with alcohol acting as a reinforce,perpetuating 
alcohol use. 
          Thus, alcohol dependence may be aptly described as a biopsychosocial 
disorder, with a complex interplay of environmental, genetic and psychosocial 
factors. 
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Etiological factors in alcohol abuse 
1. Biological Factors 
i. Genetic vulnerability (family history of substance 
use disorder; for example in type II alcoholism) 
ii. Co-morbid psychiatric disorder or personality 
disorder 
iii. Co-morbid medical disorders 
iv. Reinforcing effects of drugs (explains continuation 
of drug use) 
v. Withdrawal effects and craving (explains continuation 
of drug use) 
vi. Biochemical factors (for example, role of 
dopamine and norepinephrine in cocaine, 
ethanol and opioid dependence) 
2. Psychological Factors 
i. Curiosity; need for novelty seeking 
ii. General rebelliousness and social non-conformity 
iii. Early initiation of alcohol and tobacco 
iv. Poor impulse control 
v. Sensation-seeking (high) 
vi. Low self-esteem (anomie) 
vii. Concerns regarding personal autonomy 
viii. Poor stress management skills 
ix. Childhood trauma or loss 
x. Relief from fatigue and/or boredom 
xi. Escape from reality 
xii. Lack of interest in conventional goals 
xiii. Psychological distress 
3.Social Factors 
i. Peer pressure (often more important than 
parental factors) 
ii. Modelling (imitating behaviour of important 
others) 
iii. Ease of availability of alcohol and drugs 
iv. Strictness of drug law enforcement 
v. Intrafamilial confl icts 
vi. Religious reasons 
vii. Poor social/familial support 
viii. ‘Perceived distance’ within the family 
ix. Permissive social attitudes 
x. Rapid urbanisation 
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Management of alcohol related problems 
Early intervention 
          Studies have shown that early, brief intervention can be very useful. A trial 
period of reduction of drinking or abstinence and review of the presenting 
problems can be suggested. 
           Abstinence must be strongly advised in the following most vulnerable
groups such as  patients with a serious problem or a potential risk of serious 
problems with alcohol (dependent use  family history of dependence, physical 
illness  such as  liver dysfunction, cognitive impairment, psychiatric illness, and 
during pregnancy, serious social crises, e.g. threat of job loss or separation of 
family). 
            Clear statement of the physician’s medical concern, involvement of the 
care givers and significant others in counseling and a joint agreement with the 
patient regarding the treatment goal have been shown to have significant results 
in early stage drinkers. 
          All alcohol dependents should be motivated for longer and more intensive 
treatment programmes.  Monitoring health and drinking state at every follow-up 
is crucial to maintain the benefits of treatment. 
For dependence 
          For patients with dependence, treatment consists of managing withdrawal-
related syndromes and long-term treatment. Withdrawal, it, is best treated 
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pharmacologically, whether dependence is moderate or severe to avoid 
neurotoxicity associated with abrupt withdrawal of alcohol from the brain. 
         Outcome will be similar whether treated as outpatient (or) inpatient care is 
preferred in the following situations serious physical or psychiatric illness, at risk 
for seizures or delirium, failed-outpatient detoxification, poor social supports and 
severe alcohol craving. 
management of the dependent alcoholic include: 
         Thorough clinical examination and investigations for assessment of 
nutritional impairment, electrolyte imbalance, cardiac,hepatic, gastrointestinal 
and neurological impairment. 
         Adequate nutrition and rest.  Oral or parenteral B-complex can be        
provided, including 50 to 100 mg thiamine, for 7 to 10 days.  Symptomatic 
treatment of underlying problems such as gastritis, diarrhea or dehydration. 
Detoxification 
          Drugs commonly used to control withdrawal symptoms are the long-acting 
benzodiazepines (diazepam 5 to 10 mg or chlordiazepoxide 25 to 50 mg 6 
hourly) to ameliorate the withdrawal symptoms.  
          In the presence of liver dysfunction Short-acting benzodiazepines
(lorazepam 1 to 2 mg or oxazepam 15 to 30 mg repeated four hourly) are 
preferred . 
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         The drug dose can be reduced by 20% on subsequent days and gradually 
tapered over a week to ten days. Other drugs that are tried for detoxification 
include anticonvulsants, such as carbamazepine, phenytoin, gabapentin, alpha-
adrenergic agents such as clonidine, and beta-blockers such as propranolol 
 
         Delirium tremens can be mainly managed with supportive care, correction 
of fluid and electrolyte imbalance, antibiotics for control of infection, high doses 
of benzodiazepines along with parenteral B-complex.  
          Antipsychotics, such as haloperidol in low doses (2.5 to 5 mg) may be 
helpful in controlling agitation, but must be used carefully as they may reduce 
seizure threshold. Alcohol withdrawal seizures do not need long-term 
anticonvulsant treatment. 
           Following detoxification, the patient’s motivation is strengthened through 
individual, group and family counselling.  
           Following are included in the counseling educating about alcoholism, 
interventions to deal with interpersonal, marital, sexual problems, vocational 
counselling, helping the patient develop better skills of communication, 
assertiveness (e.g. handling peer pressure), problem solving and dealing with
stress. The family is supported and helped to provide a supportive environment 
to the patient to facilitate recovery. 
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          For women alcoholics, gender-sensitive treatment programmes addressing 
psychological and family issues more intensively, need to be provided. Self-help 
groups, such as the alcoholic anonymous (AA) and Al-Anon, for families are 
perceived as useful by many patients. Treatment of less severely dependent 
alcoholics in rural areas has also been successfully carried out through camps. 
Pharmacotherapy for long-term treatment  
          Treatment Psychological and medical supportive measures are required
throughout  withdrawal  many  CNS sedatives like barbiturates, phenothiazines,
have been used as replacement Therapy in the past (to reduce withdrawal
syndrome) but benzodiazepines  like(chordiazepoxide, diazepam) are the favored
drugs now. These have a extended duration of action and can be slowly
withdrawn later. 
Naltrexone: Numerous studies have established involvement of opioid system in 
the enjoyable reinforcing effects of alcohol probably by diminishing dopamine 
mediated reward function. Studies between post-alcohol dependent have shown 
that the long acting opioid antagonist naltrexone helps prevent relapse of 
alcoholism. It reduced alcohol craving, number of drinking days and chances of 
continued excess drinking. Naltrexone is accepted by US-FDA for use as 
adjuvant in comprehensive management programmes for alcohol dependent 
patients. In our country majority of deaddiction centres, use naltrexone after the 
individual has undergone withdrawal and is motivated. 
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Acamprostate 
          It is a weak NMDA-receptor antagonist with uncertain GABAA receptor 
agonistic action .that is being tried in European countries for maintenance 
therapy of alcohol cessation. In combination with communal and motivational 
treatment, it has been found to decrease revert of the drinking behavior.  The 
usefulness of acomprostate in this regard is valued similar to naltrexone. 
           Ondansetron  a  5-HT3 antagonist and the anti seizure drug topiramate 
have also shown some usefulness in the management of  alcoholism. 
Aldehyde dehydrogenase inhibitors 
Disulfiram  
           The enzyme aldehyde dehydrogenase inhibited by disulfiram most likely
after change into active metabolites. When alcohol is consumped after taking 
disulfiram, the level of acetaldehyde in tissues and blood increases and a lot of 
extremely disturbing symptoms (aldehyde syndrome) are formed quickly. 
Symptoms ar— hot flushing, burning sensation, severe  headache, increased 
sweating, uneasiness,  chest tightness, dizziness, vomiting, visual problems, 
alteration in the mentation, postural fall  and circulatory collapse. Spell of the 
syndrome (1–4 hours) be influenced by on the amount of alcohol taken.  Because
of risk of adverse  reaction, disulfiram is  not frequently used. Disulfiram has 
been given as an aversion method in chronic alcoholics who are encouraged and 
genuinely desire to leave the alcohol intake. After stopping alcohol after  8- 12 
hours  preferably after overnight, disulfiram is given 1 g on  day one, 0.75 g on 2
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day two , 0.5 g on day 3  and 0.25 g afterwards.  Aldehyde syndrome to alcohol 
develops after 2–3 hours of first dose, touches its peak at ~12 hours and lasts for 
7–14days after discontinuing it, because inhibition of aldehyde dehydrogenase 
with disulfiram is irreversible: synthesis of new enzyme is necessary for return 
of activity. Thus, the patient resolve not to consume alcohol is reinforced by the 
disturbing symptoms that occur if he takes a little bit of alcohol it should not 
begiven to the individuals who are physically dependent on alcohol. 
 
         Side effects of disulfiram (as such) are not frequent; include skin reactions, 
metallic taste, nervousness, easy fatigue ability and abdominal discomfort. It 
inhibits a number of other enzymes as well including alcohol dehydrogenase, 
dopamine hydroxylase. 
Mechanism of action of disulfiram 
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Monitoring and Follow-Up 
         Alcoholism, like other chronic illnesses such as hypertension or diabetes 
has a chronic, relapsing course. While 50% to 60% of patients significantly 
reduce their drinking or abstain for 6 months, relapse is frequent. Follow-up, 
therefore is mandatory and is very useful in bringing the patient back into 
treatment.  In addition, as end stage problems are more resistant to treatment, the 
focus needs to shift to early detection and intervention for alcohol-related 
problems. 
Alcohol  intoxication Alcohol intoxication  
        Acute intoxication is a temporary illness resulting after administration of 
alcohol resulting in disturbances in level of consciousness, cognition, perception, 
affect or behavior, or other psychophysiological functions and responses. This is 
usually associated with high blood levels of the alcohol.  However, in certain 
cases where the threshold is low (due to a serious medical illness such as chronic
renal failure or idiosyncratic sensitivity) even low dose may lead to intoxication. 
The severity of intoxication reduces with time, and effects in due course vanish
in the absence of further use of the alcohol. 
 The recovery is complete, excepting where tissue damage or another problem
has arisen.  
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          The following codes may be used to indicate whether the acute 
intoxication was associated with any complications: 
i. uncomplicated 
ii. with trauma or other bodily injury; 
iii. with other health complications (such as blood vomiting, aspiration of 
vomitus); 
iv. with delirium; 
v. with perceptual distortions; 
vi. with loss of consciousness; 
vii. with seizure; and 
viii. pathological intoxication (only for alcohol).  
 
          The signs of alcoholic intoxication clinically resembles other  central 
nervous system depressant overdose .excessive drowsiness, errors of 
commission, psychomotor dysfunction, disinhibition, slurring of speech , ataxia, 
and nystagmus.  Symptoms depends on blood level of alcohol.  
          Intoxication as manifested by ataxia, dysarthria, and nausea and vomiting 
indicates a blood level 150 mg/dL, blood levels range between350 to900 mg/dL 
is highly lethal.  Marked by respiratory depression, stupor, seizures, shock 
syndrome, coma, and eventually death.  
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          The first priority in treating alcohol intoxication is to maintain vital signs 
and manage respiratory depression, managing cardiac arrhythmia.  If Aggressive 
behaviour present initially treated by reassurance if needed some force if it is not 
controllable then pharmacotheraphy should be tried with short acting 
benzodiazepine or anti psychotics like haloperidol. 
 Effects of Blood Alcohol Levels in the Absence of Tolerance 
Blood Level, g/dL Usual Effect 
0.02 Decreased inhibitions, a slight feeling of intoxication 
0.08 
Decrease in complex cognitive functions and motor 
performance 
0.20 
Obvious slurred speech, motor incoordination, irritability, 
and poor judgment 
0.30 Light coma and depressed vital signs 
0.40 Death 
 
Guidelines for safe drinking 
         Doctors are frequently requested to guide on safe ways of drinking.
Different official organizations, doctor organizations and alcoholism specialists
have put forth guiding principle in this regard, but they are not identical.  The 
following may be concluded. 
• On an average 1–2 drinks per day is generally safe. 
• Not more than three drinks on any one time 
• Consumption of >3 drinks per day is associated with recognized adverse      
   health effects. 
• Do not drive or engage in hazardous activities after alcohol. 
• Do not drink if an interacting drug has been taken. 
• Subjects with any contraindication should not  take alcohol. 
• Safe limits are somewhat lesser for females. 
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Alcohol Use disorders 
It consists of:  
 alcohol dependence 
 Alcohol abuse or harmful use 
Alcohol dependence was previously called as alcoholism. This term much like 
‘addiction’ has been dropped due to its derogatory meaning.  According to 
Jellinek, there are five ‘species’ of alcohol dependence (alcoholism) on the basis 
of the patterns of use (and not on the basis of severity). 
 A. Alpha (α) 
i. Excessive and inappropriate drinking to relieve physical and/or emotional 
pain. 
ii. No loss of control. 
iii. Ability to abstain present. 
B. Beta (β) 
i. Excessive and inappropriate drinking.  
ii. Physical complications (e.g. cirrhosis, gastritis and neuritis) due to cultural 
drinking patterns and poor nutrition. 
iii. No dependence. 
C. Gamma (γ); also called as malignant alcoholism 
i. Progressive course. 
ii. Physical dependence with tolerance and withdrawal symptoms. 
iii. Psychological dependence, with inability to control drinking 
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D. Delta (δ) 
i. Inability to abstain. 
ii. Tolerance. 
iii. Withdrawal symptoms. 
iv. The amount of alcohol consumed can be controlled. 
v. Social disruption is minimal 
 
E. Epsilon (ε) 
i. Dipsomania (compulsive-drinking). 
ii. Spree-drinking. 
 
        Earlier, it was believed that γ-alcoholism was more common in America, 
while δ-alcoholism was commoner in the wine-drinking countries such as 
France.  At present the existence of this pattern of distribution is doubted and its 
inclusion in this book is mainly for historical reasons. 
 
         Cloninger has classified alcoholism into two types, on the basis of the 
relative importance of genetic and environ mental factors. 
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classification of alcoholism 
 
 
 
        Alcohol dependence is more common in men, and has an onset in later part 
of second or early part of third decade.  The course is generally insidious. There 
is often an connected abuse or dependence of other drugs. If the onset occurs late 
in life, especially after forty years of age, an underlying mood disorder should be 
looked for. 
DSM IV give the following definition: 
         To diagnose alcohol dependence three out of seven symptoms should be 
present within 12 months period.  
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ALCOHOL DEPENDENCE 
(A) A maladaptive pattern of drinking, leading to clinically significant 
impairment or distress, as manifested by three or more of the following 
occurring at any time in the same 12-month period: 
Need for markedly increased amounts of alcohol to achieve intoxication or 
desired effect; or markedly diminished effect with continued use of the same 
amount of alcohol. 
The characteristic withdrawal syndrome for alcohol; or drinking (or using a 
closely related substance) to relieve or avoid withdrawal symptoms. 
Drinking in larger amounts or over a longer period than intended. 
Persistent desire or one or more unsuccessful efforts to cut down or control 
drinking. 
Important social, occupational, or recreational activities given up or reduced 
because of drinking. 
A great deal of time spent in activities necessary to obtain, to use, or to 
recover from the effects of drinking. 
Continued drinking despite knowledge of having a persistent or recurrent 
physical or psychological problem that is likely to be caused or exacerbated 
by drinking. 
(B) No duration criterion separately specified, but several dependence criteria 
must occur repeatedly as specified by duration qualifiers associated with 
criteria (e.g., “persistent,” “continued”). 
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Alcohol abuse: To diagnose alcohol abuse, only one symptom from the below 
mentioned is enough over a period of one year 
ALCOHOL ABUSE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 (A) A maladaptive pattern of drinking, leading to clinically significant 
impairment or distress, as manifested by at least one of the following 
occurring within a 12-month period: 
Recurrent use of alcohol resulting in a failure to fulfill major role 
obligations at work, school, or home (e.g., repeated absences or poor 
work performance related to alcohol use; alcohol-related absences, 
suspensions, or expulsions from school; neglect of children or household) 
Recurrent alcohol use in situations in which it is physically hazardous 
(e.g., driving an automobile or operating a machine when impaired by 
alcohol use) 
Recurrent alcohol-related legal problems (e.g., arrests for alcohol-related 
disorderly conduct) 
Continued alcohol use despite having persistent or recurrent social or 
interpersonal problems caused or exacerbated by the effects of alcohol 
(e.g., arguments with spouse about consequences of intoxication). 
(B) Never met criteria for alcohol dependence. 
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         There are several questionnaires used to find out alcohol used disorders.  
Commonly used tests are: 
 CAGE 
 MAST 
 AUDIT 
 
       CAGE:  It is popular in the primary care settings because of its simple 
nature.  It can find out AUD.  If it is positive, further evaluation is needed.    
 
 
MAST (Michigan Alcoholism Screening Test) 
 
         It is an age old screening test to identify alcohol related problems and 
drinking behaviour.  It contains 25 questions.  There are several modifications 
came in MAST.   
AUDIT (Alcohol use disorder identification test)
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     It was developed under the guidance of World Health Organization.  It has 10 
questions.  It has a ability not only to find out alcohol dependence, it can identify 
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patients with drinking without alcohol dependence.  It validated internationally 
in all ethnic groups.  It is the only screening test specifically developed for 
worldwide use.   
 
 
The Alcohol use disorders identification test (AUDIT) 
The AUDIT has been established to provide an accurate degree of risk across 
various culture groups, gender and age.  It was developed and evaluated over a 
period of 20 years due to its cross national standardization, the AUDIT is the 
only screening test specifically developed for worldwide use.   
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 WHO developed AUDIT as a simple measure for screening of excessive 
alcohol consumption and to help in brief assessment in the wide range of health 
care settings.  It can be used by both health care personals and non health care 
personals.   
        AUDIT was developed to identify excessive alcohol consumption pattern 
and to identify who are the people benefit from either reduction in alcohol 
consumption or cessation. 
        The AUDIT will identify three different alcohol related problems: 
 Hazardous drinking  
 Harmful drinking 
 Alcohol dependence 
 Hazardous drinking 
 There is no current medical problem in this group of patients.  This type of 
drinking pattern is of public health importance.  This pattern of alcohol drinking 
elevates the risk of harmful consequences for the drinker or others.    
Harmful use. 
 Pattern of alcohol consumption that results in physical and mental harm to 
the user. 
Alcohol dependence 
 It is usually develops after repeated alcohol consumption and is 
characterised by cluster of behavioural and cognitive and physiological 
phenomenon.   
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 Strong wish to drink alcohol  
 difficult to control over its use,  
 Continuous drinking in spite of harmful consequences.   
 Top priority given to alcohol consumption than any other activity.  
 Higher amount alcohol needed for desire effect 
 Development of withdrawal reactions, once alcohol use is discontinued. 
 These are clinical features of alcohol dependence.   
Benefits of screening 
 It provides an opportunity to gather information about patients current 
condition and to evaluate the patients about risk of excessive alcohol 
consumption.  It gives the opportunity to take preventive measures to reduce the 
alcohol related risks.   
  It has the following advantages over other tests: 
1. It identify three component of alcohol use, harzadous alcohol use, harmful 
and also possible alcohol dependence. 
2. It is brief rapid and flexible according to the situation.   
3. It also focus on recent alcohol consumption 
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The audit scoring and interpretation 
         There are total of 10 questions, each question have the score of 0 to 4.  
Maximum score possible is 40. Dependent upon score, alcohol related problems 
are classified and managed accordingly.   
 In most studies, cut off of 8 provides very good sensitivity and acceptable 
specificity for identifying alcoholic disorder.  The AUDIT is best screening tools 
in primary care settings in comparison with CAGE and MAST.   
 
 
 
 
 
 
 
 
 
56 
 
Advantages of Different Approaches to AUDIT Administration 
 
 
Questionnaire                                                     Interview 
   
Takes less time                                                 Allows clarification of 
ambiguous answers 
Easy to administer                                            Can be administered to 
patients with poor 
                                                                           reading skills 
Suitable for computer administration 
and scoring 
May produce more accurate answers                Allows seamless feedback to 
patient 
                                                                             and initiation of brief advice 
 
 
Review of studies 
 
         John B Saunders et al (1993):  When the AUDIT score of 8 or more used 
to diagnose AUD, Audit has sensitivity of 92% and specificity of 92% to 
diagnose hazardous or harmful alcohol use.  Studied done in 1088 patients who 
were attending primary health care facilities.   
          Bohn Mu et al
40
 (1995) done in a case control study shows that AUDIT 
score was superior to MAST to discriminating hazardous drinkers from non 
hazardous drinkers.   
          Gache P et al (2005)
41
 study done simultaneously in France and 
Switzerland involving 1207 patients coming to the OPD.  AUDIT shows better 
results than MAST and CAGE to diagnose alcohol abuse / dependence. 
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Biomarkers     
 
          Biomarkers have clinical usefulness for finding, diagnosis, and 
management of alcohol use disorders and also useful in screening for fetal 
alcohol exposure. 
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          There are direct and indirect bio markers but most commonly used once 
are indirect bio markers. 
Indirect biomarkers are:  
Those that reflect the lethal effects of alcohol on organs, tissues, or blood 
biochemistry.  
Indirect biomarkers include  
 hepatic enzymes  
 aspartate aminotransferase 
 alanine aminotransferase 
 gamma glutamyltransferase 
 carbohydrate-deficient transferrin   
 mean corpuscular volume. 
Direct biomarkers are products of alcohol metabolism.  
Direct biomarkers include  
 acetaldehyde adducts  
 ethyl glucuronide 
 ethyl sulfate 
 phosphatidylethanol 
 fatty acid ethyl ester 
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ASPARTATE AMINO TRANSFERASE (AST) 
         In old literature it was called as serum glutamate oxaloacetate transaminase 
(SGOT).AST needs pyridoxal phosphate (vitamin B6)as co-enzyme. Normal 
serum level of AST ranges from 8 to20 U/L. It is a marker of liver injury and 
shows moderate to drastic increase in parenchymal liver diseases like hepatitis 
and malignancies of liver. 
          AST was used as a marker of myocardial ischemia in olden days. The 
level is significantly elevated in myocardial infarction. But troponins have 
replaced AST as a diagnostic marker in ischemic heart disease 
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ALANINE AMINO TRANSFERASE (ALT) 
          In old literature, it was called as serum glutamate pyruvate transaminase 
(SGPT). The enzyme needs pyridoxal phosphate as coenzyme. 
           Normal serum level of ALT for male is 13-35 U/L and for female is 10-
30 U/L. Very high values (300 to 1000 U/L) are seen in acute hepatitis, either 
toxic or viral in origin. 
          Both ALT and AST levels are increased in liver disease, but ALT > AST. 
Rise in ALT levels may be noticed several days before clinical signs such as 
jaundice are manifested.  Moderate increase (50 to 100 U/L) of ALT may be 
seen in chronic liver diseases such as cirrhosis, hepatitis C and non-alcoholic 
steatohepatitis (NASH). 
Normal AST: ALT ratio is 0.8. A ratio >2 is seen in 
Alcoholic hepatitis 
Hepatitis with cirrhosis 
Nonalcoholic steatohepatitis (NASH) 
Liver metastases 
Myocardial infarction 
Erythromycin treatment 
A low ratio (ALT is higher) is seen in 
Acute hepatocellular injury 
Toxic exposure 
Extra hepatic obstruction (cholestasis 
 
Gamma Glutamyl Transferase (GGT  ) 
 
GGT is clinically important because of its sensitivity to detect excess alcohol 
consumption. GGT level in alcoholic liver disease roughly parallels the alcohol 
intake  Elevated levels of GGT are observed in chronic alcoholism, pancreatic
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disease, myocardial infarction, renal failure, chronic obstructive pulmonary 
disease and in diabetes mellitus.
27,28
  In liver diseases, GGT elevation parallels 
that of ALP and is very sensitive of biliary tract disease. The old name was
gamma glutamyl transpeptidase. It can transfer gamma glutamyl residues to 
substrate. In the body it is used in the synthesis of glutathione.  GGT has 11 iso-
enzymes 
 
          Normal serum value of GGT is 10-30 U/L.  It is moderately increased in 
infective hepatitis and prostate cancers.  In alcoholics even when other liver 
function tests are within normal limits. GGT level is rapidly decreased within a 
few days when the person stops to take alcohol.  Increase in GGT level is
generally proportional to the amount of alcohol. 
 
 Other liver function tests like serum bilirubin , alkaline phosphtsase , albumin , 
Prothrombin time not useful as a bio marker unless complicated by liver disease. 
Once liver disease established these markers may be useful to categorize 
decompensated liver disease 
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Mean Corpuscular Volume
43,44,45
    
 The presence of mean corpuscular volume may be an indicator of 
underlying disease.  An elevated MCV is referred as macrocytosis upper 
reference limit for mean corpuscular volume varies from 95 to 100 fl.  It 
depends upon age and laboratory.  Generally laboratories often gives upper 
reference limit as 100 fl
43
.     
                                          
 
 
Cause of Macrocytosis 
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          Mean corpuscular volume (MCV) has also long been known to 
elevate with chronic excessive alcohol intake. This elevation appears to be 
mainly because of direct morrow-toxic effects of alcohol,  alcohol does 
affect folate absorption, a true folate deficiency occurs in only 17 percent of 
chronic alcoholics, while elevated MCV is more common. And with an red 
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blood cells half life 120 days, elevated MCV is a marker of more chronic 
alcohol ingestion and it is not a good marker of acute ethanol ingestion or 
acute relapse
13
. 
          Sensitivity is between 30-75% in varies studies. Elevated MCV has 
also been shown to be more sensitive than men in women for unknown 
reasons.. An elevated MCV above the normal range has a very good 
specificity, often quoted as over 90 percent.
13,15
. Since MCV is another 
readily available, investigation its use should encouraged when a patient 
came with a features of chronic alcohol abuse and dependence
13
.  
Interestingly, in combination with AST, a normal lab value virtually rules 
out delerium tremens in emergency patients
14
. 
Review of studies 
          Seppä K.et al 1991
16
macrocytosis may be the only indicator of 
chronic alcohol ingestion , particularly in young and middle-aged men. 
          Mundle G et al  2000
17 
the "forgotten" marker MCV is superior in 
women to find out alcohol use disorder and it is a marker of second choice 
in men. The combination GGT and MCV is the most cost-effective choice 
for men and women. 
          Kumar BG Prashanth  et al2012
18 
The study shows that  elevated 
MCV to be possessing sensitivity87.5% andspecificity of, 83.33%. 
positive predictive value is 87.5% and negative predictive value 48.39%.  
Diagnostic accuracy  of the test to find out alcohol use disorder 54.29% 
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They are also helpful in  long term follow-up of patients undergoing 
treatment, and monitoring of abstinence beyond 120  days 
carbohydrate-deficient transferrin (CDT) 
          Transferrin is a protein synthesized by the liver. It involved in iron 
transportCDT refers to isoforms that are deficient in sialic acid. CDT is 
defined as the monosialo, disialo, andasialo isoforms of transferrin. Excess 
alcohol consumption increases the fraction of CDTs
19,20
. 
CDT  test has moderate sensitivity and specificity and is a longer-
term marker of excess alcohol consumption ingestion of 50 to 80 g alcohol 
per day for 1 to 2 weeks elevates CDT abovebaseline
21
because of its relative 
short half life CDT is especially useful as a marker for abstinence . and 
came back to baseline levels 2 to 5 weeks after alcoholcessation.  
The most important factor influencing CDT testing accuracy to detect 
alcohol use disorder  is gender. more false positives test results can occurs 
in women even with the newer % CDTtests
24,25
. 
Review of studies 
Sorvajärvi K. etal 1996
22  
alteration in serum total transferrin levels 
affect the specificity CDT assay. This should be kept in mind when 
interpreting the CDT results in patients with elevated serum transferrin, such 
as iron deficiency anaemia, pregnancy, and liver diseases. 
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Radosavljevic M  et al 1995
23 
an elevated carbohydrate deficient 
transferrin level, however, cannot be taken as reliable confirmation for 
chronic alcohol abuse in patients with hepatic disease. 
GURUPRASAD P et al1998
26
in patients with a “wide range of 
alcohol intakes” bio markers such as serum GGT and  MCV were more 
appropriate than serum CDT for measuring alcohol intake. Serum CDT 
when used in combination with serum GGT and MCV was useful in finding 
out excessive alcohol intake. The significance of careful alcohol history 
with a standardized questionnaire is highlighted. 
NEED FOR THE STUDY 
Physicians usually identify only half of patients with drinking 
problems for the reason that of both insufficient time spent on questioning 
by doctors and denial by patients
9
.  Underestimation of alcohol related 
problem is particularly common in older patients
10
. 
Measuring alcohol consumption in an individual has so many 
restrictions. Most studies depend on interviews with patients and their 
family members to assessment the amount, frequency and extent of alcohol 
intake. 
Patients may not accurately report the amount of alcohol they 
consume
8
 and the definition of a ‘standard drink’ varies from region to 
region
11
. 
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Patients with compensated liver disease generally do not have any 
symptoms so they do not seek medical attention. Alcohol-related problems 
are usually not detected until late when the developed decompensated liver 
disease
12
. “PREVENTION BETTER THAN CURE. BY EARLY 
DETECTION  WE CAN PREVENT  AHE ALCOHOL DEPENDENCE 
AND  ALCOHOL RELATED OTHER PROBLEM” symptoms so they do 
not seek medical attention. Alcohol-related problems are usually not 
detected until late when the developed decompensated liver disease
12
. 
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MATERIALS AND METHODS 
 This is a cross sectional study and it was conducted at the Institute of 
Internal Medicine, Madras Medical College & Rajiv Gandhi Government 
General Hospital, Chennai-3 for a period of six months from June 2013 to 
November 2013.   The protocol for this study was approved by the 
Institutional Ethical Committee (IEC), Madras Medical College & Rajiv 
Gandhi Government General Hospital, Chennai-3. 
INCLUSION CRITERIA 
 For participation in this study: 
Patients admitted in the medical wards found to having alcohol use 
disorders which was identified by using the AUDIT score. 
EXCLUSION CRITERIA 
 Patients not willing to participate in the study after clear 
explanation. 
 Patients who are having anemia. 
 Patients who are having thyroid disorders. 
 Pregnant women 
 Patients who are taking anti epileptic drugs. 
 Patients who are taking chemotherapeutic drugs. 
 Patients who are antiretroviral drugs 
After meticulous assessment of inclusion and exclusion criteria, 100 
patients were enrolled in this study.   
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Verbal explanation about this study was clearly enlightened to the 
participants and the doubts in this study was heard and clarified. From those 
who are willing to enrol in this study an informed consent in the prescribed 
format which was submitted to the ethical committee was obtained.   
Participants who cannot understand the English language, a consent 
was obtained in the mother tongue (Tamil), so that the participants can have 
better understanding about the study details.   
From the eligible subjects, history related to current medical problem, 
past history, personal history pertaining to smoking, drug abuse and high 
risk sexual  behaviour were recorded.  Occupational history was also 
obtained.   
Alcoholic History 
 Detailed history of alcohol intake was recorded as per AUDIT 
proforma interview version by World Health Organization.  Age of 
initiation of alcohol and family history of alcohol use disorders were also 
obtained.  It was explained about what is standard drink and questions are 
asked as per proforma.  Total of 10 questions asked and score given 0 to 4 
according to their response.  Sub scores were made according to the 
questions answered. 
Consumption score was made by adding up of question numbers 1 to 
3, total sub score possible is 12.  Any score more than 6 is significant.  
Dependence score was made by adding up to scores of answer given to 
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question numbers 4 to 6 and total sub score possible is 12.  Score more than 
4 is significant.   
Alcohol related problem score was made by answer given to question 
numbers 7 to 10 and total score possible is 16.   
Risk stratification which is useful in management done as per score 
given in the below tables: 
 
These subjects were subjected to general examination, measurement 
of vitals and systemic examination to find out alcohol related problems and 
any other associated medical problem.  Measurement of blood pressure was 
done in a quiet room patient was seated position for five minutes, well 
calibrated and accepted blood pressure machine with appropriate cuff size, 
working on mercury scale was used to measure the resting blood pressure.  
Blood pressure was recorded in the two arms and the highest of these two 
recording were mentioned.  Patient who were on medication for blood 
pressure control were allowed to take morning dose of scheduled drugs and 
blood pressure was recorded under protective cover of anti hypertensive 
only.   
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Assays and Calculations: 
 Under strict aspetic precaution, sufficient blood samples were drawn, 
biochemical analysis which includes random blood sugar, blood urea, serum 
creatinine and liver function test which includes serum bilirubin, aspartate 
amino transferase, alanine amino transferase, alkaline phosphoatase, serum 
albumin were done by auto analyser at central biochemistry laboratory at 
Rajiv Gandhi Government General Hospital, Chennai.  For complete blood 
count, blood samples were collected from ante cubital vein using syringe 
and transferred to EDTA tube and analysed in automated cell counter 
sysmex KX21 and anslysed.   
 Peripheral smear was done at Pathology Lab at Rajiv Gandhi 
Government General Hospital, Chennai-3.   Ultrasonagram of abdomen was 
done at Bernard Institute of Radiology, Rajiv Gandhi Government General 
Hospital, Chennai-3. 
Criterias used were: 
Blood Pressure >140/90 mmHg or <140/90 mmHg with anti 
hypertensive medications as per JNC VII guidelines (Joint National 
Committee on prevention, detection, evaluation and treatment of High 
Blood Pressure). 
Total AUDIT score 8 and above is taken as alcohol use disorders. 
Mean Carpuscular volume of >100 fl as taken as macrocytosis. 
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Statistical methods 
 Data reported in this study includes descriptive statistics of 
participants at the time of enrolment.   Qualitative variables are analysed by 
chi-square test. The quantitative data in this study were analysed using 
independent sample t test.   
Sponsorship 
 Nil 
Conflict of Interest 
 None 
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OBSERVATIONS AND RESULTS 
Table 1 : AGE GROUP AND MACROCYTOSIS 
Age group (in yrs) MCV >100fl MCV <100fl 
20 – 30 07 06 
31 – 40 20 14 
41 – 50 20 12 
51 – 60 08 07 
>60 04 02 
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Table 2 : ALCOHOL USE DISORDER AND MACROCYTOSIS 
Alcohol use disorder 
(No. of patients) 
MCV >100fl MCV <100fl 
100 61 39 
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Table 3 : RISK STATIFICATION USING AUDIT SCORE AND 
MACROCYTOSIS 
Zone MCV >100fl MCV <100fl 
Zone I  
(Score 0 – 7) 
0 0 
Zone II 
(Score 8 – 15) 
04 06 
Zone III 
(Score 16 – 19) 
07 05 
Zone IV 
(Score 20 – 40) 
50 28 
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RISK STATIFICATION USING AUDIT SCORE AND MACROCYTOSIS 
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Table 4 : AST / ALT RATIO AND MACROCYTOSIS 
 
AST/ALT ratio 
<1 
AST/ALT ratio 
1 – 2  
AST/ALT ratio 
>2 
MCV <100 fl 09 25 05 
MCV >100 fl 10 37 14 
Total 19 62 19 
 
 
 
MCV
> 100< 100
C
o
u
n
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40
30
20
10
0
AST/ALT
< 1
1-2
2-3
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Table 5 : Alcohol use disorders in medical ward patients and admission 
diagnosis 
Sl.No. Diagnosis 
No.of patients 
(%) 
1. Hepatobilliary 36% 
2. Neuro-psychiatry 32% 
3. Infection 17% 
4. Gasterointestinal 15% 
5. Cardiovascular 7% 
6. Self harm 3% 
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Alcohol use disorders in medical ward patients and admission diagnosis 
 
80 
 
 
Table 6 : ALCOHOL USE DISORDER AND HYPERTENSION 
Alcohol use disorder 
(No. of patients) 
Systolic 
Hypertension 
Diastolic 
Hypertension 
100 25 33 
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Table 7 : ALCOHOL USE DISORDERS AND OCCUPATION 
Sl.No. Occupation 
No.of patients 
(%) 
1. Others 43% 
2. Drivers 20% 
3. 
Construction 
workers 
17% 
4. Hospitality 8% 
5. Other daily wagers 7% 
6. Students 4% 
7. Unemployed 1% 
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ALCOHOL USE DISORDERS AND OCCUPATION 
 
 Table 8 : ALCOHOL USE DISORDERS AND USG ABDOMEN 
FINDIDNGS 
Sl.No. 
USG abdomen 
findings 
No.of patients (%) 
1. Fatty Liver 41% 
2. Normal Study 34% 
3. DCLD 23% 
4. Others 2% 
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Table 9 : ALCOHOL USE DISORDERS AND SMOKING 
 
Alcohol use disorder 
(No. of patients) 
Smokers Non Smokers 
100 52% 48% 
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Table 10 : ALCOHOL USE DISORDERS AND HIGH RISK SEXUAL 
BEHAVIOUR 
 
Alcohol use disorder 
(No. of patients) 
High Risk 
sexual behavior 
present 
High Risk sexual 
behavior absent 
100 12% 88% 
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RESULTS 
Total number of participants in this study was 100 in number who 
were found to having alcoholic disorders.  An analysis of these group of 
people, macrocytosis was noted in 61% and the remaining 39% had normal 
mean corpuscular volume. 
Age and Macrocytosi 
 In this study, alcoholic disorder prevalence is higher among age group 
of 31 to 40 years (34%) and 41 to 50 (32%) contributing around 66% of 
patients.  Alcohol use disorders is prevalent in the productive age group but 
there is no statistical difference among age grouping macrocytosis.  The 
youngest one noted in this study was 20 years and elder one was 75 years.  
So, problem is common in all age groups.   
Risk stratification using AUDIT score and macrocytosis 
 Risk stratification done by total AUDIT score shows that 78% of 
patients were in high risk zone who requires immediate intervention among 
patients belong to high risk zone 50 had macrocytosis and 28 had normal 
mean corpuscular volume.  12 patients were belong to the moderate risk 
group who requires counselling for alcohol related problems.  7 of them had 
macrocytosis, 5 had normal mean corpuscular volume.  10 patients belong 
to zone II.  These patients needs simple advise for alcohol related problems.  
Patients having more AUDIT score showing statistically significant p value 
(0.028).    
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AST / ALT ratio and macrocytosis 
 AST/ALT is one of the biomarker to identify alcohol related 
problems.  AST/ALT ratio between 1 to 2 presented in 62% of people, 
among them macrocytosis presented in 60.7%.  AST/ALT ratio of more 
than 2 presented in19 patients, among them 14 patients had macrocytosis 
which contribute to 73.7% patients in that group.   
 Using chi-square test, AST/ALT ratio 1 to 2 have significant 
associated with macrocytosis with p value of 0.0001. 
Alcohol use disorder in medical ward inpatient 
 Patients who were admitted in medical wards who were found to 
having alcohol use disorders which was confirmed by AUDIT shows that 
36% of patients had hepatobillary system involvement.  In the hepatobillary 
system decompensated liver disease contributes to 23 cases and 1 patient 
had hepatocellular carcinoma.   
 32% of patients admitted had neuro psychiatric problems like alcohol 
intoxication, alcohol withdrawal and others.   
 Next major contributor is infection.  It causes 17% of patients.  
Gasterointerstinal system involved in 15% of patients.  It is mainly due to 
alcoholic gastritis.  One had esophageal carcinoma and one had carcinoma 
stomach.   
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 Alcohol known to cause high risk behaviour, self harm presented in 
three patients.  One had attempted hanging, two admitted for allerged 
consumption of poisoning.   
Alcohol use disorder and hypertension 
 In the total of 100 patients, 33 patients had diastolic hypertension and 
25 had systolic hypertension.  2 patients admitted for emergency 
management of accelerated hypertension.  Among 33 patients, only 20 
patients knows that they were having hypertension.  In the 20 patients, only 
15 patients were on the regular medications.   
Alcohol use disorder and Occupation 
 Alcohol use disorders were widely prevalent in all socio economic 
groups.  Previously it thought that it was prevalent only in low socio 
economic groups.  It uniformly spread among all groups.  37% patients were 
contributed by drivers (20%) and construction workers (17%).  Students 
contributed 4%.  Other daily wagers like load man, agriculturist contributes 
to 7%.  Persons who were working in hotels, bar are more prone to develop 
AUD at younger age group because of easy availability of alcohol.  8% of 
patients were belong to these groups.  In this study one person is 
unemployed.  The remaining 43% distributed evenly in all other categories.   
Alcohol use disorder and USG abdomen findings 
 A well known fact that alcoholism leads on to fatty liver disease.  It is 
prevalent upto 90%, but in our study 41% of patients had fatty liver, 23% 
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patients had decompensated liver disease which is the advanced spectrum of 
fatty liver disease.  Normal study was noted in 34% of people, one person 
had bilateral medical renal disease. 
Alcohol use disorder and smoking 
 In our study group, 52% of patients used tobacco mainly in the form 
of smoking and they continue to using regularly.  48% were non smokers.  
None of the person had any other oral or IV drug abuse history.   
Alcohol use disorder and high risk sexual behaviours 
 In our study group, 12% patients had high risk sexual behaviour like 
multiple partners, unprotected sex and MSM (Man seeking Men) sex. 
Among this 12 patients, 3 patients diagnosed to having retroviral disease 
after admission.  88% of patients did not had high risk sexual behaviour. 
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DISCUSSION 
In our study, the prevalence of macrocytosis in patients with AUD is 
61% with p value of 0.028.   
 As per study done by GA Gomex et al
50
, the study conducted in 
hospitalised inpatients both compressing of medical and surgical patients 
shows that mean corpuscular volume as a sensitivity and specificity of 74% 
to diagnose alcohol use.   
 Kumar PG Prashanth et al (2012) done a case control study in India 
involving 40 cases and 30 controls shows that elevated MCV has 87.5% 
sensitivity and specificity.  MCV also useful in monitoring long term 
abstinence51.   
 As per study done by S.Chaudhury et al, a case control study 
conducted in India, 100 male inpatients admitted in psychiatric hospital for 
alcohol dependence shows that MCV sensitivity of 31% and specificity 
of100%
52
.   
 As per summary released by National Institute of Alcohol abuse and 
alcoholism shows that MCV has sensitivity of 47% to diagnose AUD.  The 
study was done by Anttila et al 2004.   
 
 A study done by Seppa K et al in 1991, macrocytosis as a common 
findings in patients who were not anaemic and without other haematological 
abnormalities was generally ignored.  The study involved 300 patients 
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attending general practitioners who has macrcytosis.  80.2% of men and 
34.1% of women are alcohol abusers.   
 As per Seppa K et al (1992) comparison of alcohol use- macrocytosis 
and blood pressure case study involving 95 patients and 22 controls shows 
that 72% of men with macrocytosis were alcoholic and 41 of them had 
either systolic or diastolic blood pressure.  In female patients, the systolic 
blood pressure is normal and slight elevation in diastolic blood pressure.   In 
our study, prevalence of diastolic hypertension is 33% and systolic 
hypertension is 25%.   
 Pandey et al conduct a prevalence study with a help of Indian Council 
of Medial Research conducted in patients who had sexually transmitted 
disease.  26% of patients who were having sexually transmitted disease 
were alcoholic user.  In our study, three persons had retroviral disease.   
 As per Nyblom H et al study done at three different groups, first 
group comprises of patient with alcoholic dependence.  The total number of 
patients were 313.  Second group has 78 patients with the history alcohol 
abuse and third group 48 patients with alcohol abuse and cirrhosis and its 
complications.  The study shows that patient without liver disease does not 
have high AST/ALT ratio.  AST/ALT ration above 1 indicator for advanced 
liver disease.  In our study 81% of patients AST/ALT ratio more than 1.  
62% of patients had ratio between 1 and 2 and 19% had ratio more than 2.  
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It may be because of high prevalence of hepatobillary system involvement 
in our study.   
 As per study Mohan D et al (2002) done in representative of general 
population in capital of India.  Over 5414 men and 4898 women shows that 
prevalence of concurrent smoking and alcohol is 9.6% in general 
population.   
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LIMITATIONS OF STUDY 
 
 One limitation of our study involved low number of participants in 
comparison to other studies.  Hence, these results need to be confirmed in 
large group of patients and longitudinal studies.  There were no women 
participants in this study to compare the effect of AUD and macrocytosis in 
them.   
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CONCLUSION 
 Diagnosing alcohol injection after development of alcohol 
dependence or alcohol related problems has no value in the management.  A 
combined use of AUDIT and cost effective investigations like mean 
corpuscular volume.  We can diagnose the problem earlier and we can 
prevent the complications.   
 Patients with macrocytosis without anaemia should be evaluated for 
alcohol abuse.   
Mean Corpuscular volume the only biomarker that reduce long time 
after alcohol cessation.  It has to be studied to follow up of long term 
abstinence.   
Large community based studies needed involving alcohol users 
without complications to find out usefulness of this test.        
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ABBREVIATIONS 
AUDIT  : Alcohol Use Disorders Identification Test 
MCV  : Mean Corpuscular Volume 
AUD   : Alcohol Use Disorders 
AST   : Aspartate Amino Transferase 
ALT   : Alanine Amino Transferase 
gm   : Grams 
dL   : Deciliter 
IU   : International Unit 
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PROFORMA 
Name     :    Age :  Sex: 
IP No.    :    Occupation: 
History of present illness  : 
Past History    : 
Personal History   : 
Alcohol History as per AUDIT  : 
General Examination  : 
Systemic Examination  : 
Investigations   : 
CBC     : 
Peripheral Smear   : 
RFT     :  
LFT     : 
Thyroid Function Test  : 
USG abdomen   : 
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 
1 Manikanadan 27 M 65196 H - - 130 90 19 7 8 4 87.3 38 40 <1 1.2 12 3.5 NSY AG H 
2 Arumugam 26 M 66459 C - - 100 70 26 9 8 9 106.5 329 109 >2 23.8 109 4.6 Fatty liver AI NS 
3 Venkatesan 32 M 68827 D - - 100 70 25 10 6 9 128.6 302 118 >2 2.2 160 4.5 
Gr.I Fatty  
liver 
ChP 
Hepato 
billary 
4 Vinoth 26 M 68903 S - - 110 70 10 6 4 - 113.1 60 48 >1 1.3 72 4 
GB Wall  
thickening 
Fever infection 
5 Prakash 35 M 68903 H + - 120 90 32 12 6 12 102.6 146 74 >1 1.6 64 3.7 Fatty liver AI NS 
6 Suresh 32 M 63951 D + - 140 90 26 10 6 19 88.2 37 33 >1 0.9 95 3.9 NSY AG GIT 
7 Venkatesan 40 M 64281 H + - 100 70 24 10 6 8 87.6 86 31 >2 1.3 30 3.8 
Liver 
absess 
AL 
Hepato 
billary 
8 Veeraragavan 42 M 64266 C + - 90 70 26 12 6 8 102 42 38 >1 1.2 31 3.2 NSY SVT CVS 
9 Seenu 40 M 68909 U - - 130 80 22 10 6 6 81.4 116 100 >1 13.7 300 3.6 NSY AWS NS 
10 Arunachalam 55 M 68956 O - - 140 90 22 10 6 6 102.2 42 40 >1 1.2 72 3.4 fatty liver AWS NS 
11 Venkatesan 52 M 70641 C - - 100 70 18 8 4 6 86.5 97 88 >1 1.4 97 2.5 NSY TB Infection 
12 Devadoss 35 M 113051 D + - 140 100 20 8 6 6 101.5 239 345 <1 20.8 525 3.4 
Hepato 
cellular 
carcinoma 
HCC 
Hepato 
billary 
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 
13 Jayasingh 43 M 77265 C + - 100 60 27 10 7 10 97.5 92 46 >2 5.2 157 2.6 DCLD DCLD 
Hepato 
billary 
14 Arumainathan 40 M 78666 O - - 100 70 30 10 10 10 92.6 51 41 >1 4.1 90 3.7 DCLD DCLD 
Hepato 
billary 
15 Vardharajan 40 M 78830 O + + 90 60 20 8 6 6 78.7 34 35 <1 1.2 130 3 NSY 
Alcoholic 
DCM 
CVS 
16 Kasi 46 M   O - - 140 90 26 12 8 6 104.6 48 42 >1 1.7 124 3.8 
Fatty 
liver 
ALD 
Hepato 
billary 
17 Sridhar 65 M 73700 O + - 150 100 30 10 6 16 106.1 78 46 >1 3.2 46 2.8 
Fatty 
liver 
AWS NS 
18 Yuvaraj 33 M 71297 O - - 140 90 32 10 8 14 90.9 178 187 <1 4.2 187 3.8 
Fatty 
liver 
AWS NS 
19 Mathesh 45 M 71232 O + - 130 80 28 10 8 10 116.8 42 36 >1 1.2 52 3 NSY AG GIT 
20 Gunasekar 44 M 71327 O - - 100 70 28 10 6 12 103.3 69 270 <1 10 286 3.2 DCLD DCLD 
Hepato 
billary 
21 Sakthivel 39 M 72431 O - - 130 80 30 10 8 12 95.4 59 46 >1 0.9 101 3.9 
Fatty 
liver 
AG GIT 
22 Sekar 46 M 81204 O - - 110 70 32 12 8 12 87.5 402 196 >2 6.8 206 2.5 
Fatty 
liver 
AH 
Hepato 
billary 
23 Raghu 42 M 81264 O - + 100 60 20 10 4 6 106.2 32 26 >1 0.8 134 3 NSY 
Lung  
Absess 
Infection
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 
24 Marriappan 38 M 81365 D + + 100 70 26 10 6 10 97.4 42 40 >1 8.6 48 2.2 DCLD DCLD 
Hepato
billary
25 Kuppan 55 M 83546 O + - 94 60 26 10 6 10 112.2 40 32 >1 2.8 65 3.7 DCLD DCLD 
Hepato
billary
26 Nehru 56 M 83802 O - - 100 70 28 10 8 10 107.6 88 42 >2 4.8 106 3 DCLD DCLD 
Hepato
billary
27 Venkatesan 37 M 83906 C - - 130 100 24 10 8 6 110.6 42 36 >1 1.9 60 3.5 NSY AG 
28 Ramesh 28 M 83957 D + + 140 90 32 12 8 12 93.7 92 86 >1 8.6 116 3.2 Fatty liver AH 
Hepato
billary
29 Palanikumar 38 M 86061 H - - 100 70 25 9 6 10 116 46 36 >1 1.8 206 3.2 DCLD DCLD 
Hepato
billary
30 Sivaprakash 39 M 86002 C + - 104 70 19 8 5 6 101.1 60 46 >1 2.7 99 4 DCLD DCLD 
Hepato
billary
31 Ramu 52 M 88741 H - - 160 100 30 12 8 10 86.5 40 42 <1 0.9 26 3.2 NSY AWS 
32 Kannan 48 M 86123 H + - 90 60 16 6 4 6 105.9 52 50 >1 1.3 67 2.9 ascites 
CAD 
DCM 
DM 
33 David 40 M 88735 O - - 100 70 22 10 5 7 90.9 64 62 >1 1.6 106 3 
Secondary 
Liver 
Ca 
stomach 
Gr.IV 
34 Sudhakar 32 M 91321 D - - 114 70 20 8 6 6 92.3 38 40 <1 1.2 56 3 NSY RVD Infection
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 
35 Gowthaman 56 M 912456 O + - 150 100 35 12 10 13 104.8 88 43 >2 1 76 3.5 NSY PN 
36 Ramesh 42 M 91113 O + - 140 90 27 12 6 9 92.3 44 71 >1 1.2 36 3.2 Fatty liver CVT 
37 Ramesh 38 M 91310 O + - 138 90 23 10 5 8 112 40 71 >1 1.3 46 3.5 NSY 
Young 
stroke 
38 Chandrakumar 49 M 91752 C + - 150 100 32 12 8 12 97.5 48 71 >1 1 48 2.5 Fatty liver AWS 
39 Marimuthu 46 M 91438 ODW - + 100 70 34 12 8 14 102.6 140 71 >1 2.4 168 3 Fatty liver ACP 
40 Ramamurthy 48 M 113236 O + - 130 94 23 12 6 5 104.1 329 109 >2 23.8 109 4.6 Fatty liver AH 
41 Ravi 52 M 108881 O + - 120 70 14 8 6 - 95 38 40 >1 0.9 52 3.2 NS 
CAD/ 
old 
IWMI 
42 Nuthankumar 37 M 115914 O - - 140 100 24 8 6 10 108.7 48 102 <1 1.8 106 4 fatty liver AG 
43 Mari 37 M 115889 D - - 100 70 26 8 8 10 121 44 40 >1 1.9 55 4.3 Fatty liver AG - DM 
109 
 
44 Karthick 20 M 115650 S - - 100 70 9 5 4 - 96.2 52 50 >1 1 39 3.5 NSY Fever 
45 Sugukumar 49 M 116675 O + - 190 110 21 7 5 9 106.6 66 85 <1 1.2 209 3.31 Fatty liver 
Acute 
CVA 
ICH/SHT 
46 Dhanasekar 40 M 115895 C + - 150 100 32 10 8 14 102 194 86 >2 1.8 166 3.4 Fatty liver AWS 
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 
47 Karthick 32 M 1E+07 D + - 130 80 30 10 8 12 93.1 88 66 >1 2.8 56 3 
Fatty 
liver 
AWS NS 
48 Venugopal 38 M 115929 D + - 130 100 15 7 4 4 87.5 70 52 >1 1.2 52 2 NSY CVT NS 
49 Feroze 24 M 115203 S - - 120 80 12 8 4 - 112.1 45 28 >1 0.8 114 3.9 NSY poisoning Self harm 
50 Munusamy 47 M 116034 C + + 110 70 30 10 8 12 102 346 160 >2 4.9 158 3.6 
Fatty 
liver 
AH 
Hepato 
billary 
51 Nithyanandan 26 M 106125 H - - 100 70 12 8 4 - 112.9 57 35 >1 1.3 49 3.5 NSY Fever Infection 
52 velu 47 M 106229 ODW + - 110 70 24 10 9 5 97.3 86 44 >1 1.2 106 3.2 MLS 
Ca  
Oesophagus 
GIT 
53 Marimuthu 40 M 108376 ODW + - 100 70 32 12 9 11 105.2 114 48 >2 0.8 66 2.5 
Fatty 
liver 
AI NS 
54 David 53 M 108470 C - - 110 70 24 10 6 8 100.8 55 66 >1 0.8 116 3.8 NSY AWS NS 
55 Natarajan 50 M 110811 O + - 100 70 27 10 9 9 106.5 52 48 >1 2.8 1.7 3.7 DCLD DCLD 
Hepato 
billary 
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56 Padmanabhan 47 M 108492 D + + 120 70 20 10 6 4 92.6 48 50 <1 0.8 72 2.3 NS RVD Infection 
57 Arumugam 42 M 109652 D + - 114 70 23 10 5 8 109.7 156 102 >1 1.2 32 3.2 
CM 
Liver 
absess 
Liver 
absess 
Infection 
58 Ethiyappan 26 M 109772   + + 100 70 18 8 6 4 88.3 42 46 <1 1 78 3.2 NSY RVD Infection 
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 
59 Chellappan 48 M 110919 O + - 210 130 18 10 4 4 100.2 56 68 <1 0.9 116 3.8 NSY 
AHT/Acute 
CVA 
CV 
60 Murugan 44 M 103442 D + - 120 80 27 7 6 14 91.4 48 44 >1 1 96 4 Fatty liver Old PTb Infection 
61 Govindasamy 32 M 103537 ODW - - 100 60 23 9 5 9 121 52 48 >1 1.2 74 3.8 Ascites CAD/ECF CV 
62 Ellappan 60 M 103495 O - - 150 90 34 12 12 10 102.8 188 36 >2 2.8 196 3 Fatty liver AI NS 
63 Murugesan 47 M 103868 D + - 100 60 33 10 9 14 109 126 42 >2 8.8 226 3.5 DCLD DCLD 
Hepato 
billary 
64 Mani 56 M 103726 ODW - - 150 90 16 6 4 6 97.7 56 44 >1 0.7 162 2.8 NSY CAD/CA CVS 
65 Damotharan 48 M 103786 ODW - - 110 70 23 9 8 6 107.8 114 88 >1 1.4 104 2.8 NSY 
Growth  
Oesophagus 
GIT 
66 Selvakumar 75 M 104276 O - - 96 70 16 8 4 4 101 166 82 >1 2.2 112 3.3 NSY CAP Infection 
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67 Rajendran 47 M 105768 D + + 120 70 26 12 8 6 86.7 58 49 >1 1.4 102 3 Fatty liver CVT NS 
68 Hamaiyan 65 M 105794 O + - 100 70 19 10 5 4 102.9 172 100 >1 2.4 206 3.2 
Secondary 
Liver 
Ca stomach 
Stage IV 
GIT 
69 Prabhadoss 25 M 105869 S - - 96 60 36 12 10 14 92.3 486 208 >1 16.7 140 2.8 AL PHF 
Hepato 
billary 
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 
70 Nagaraj 61 M 108787 O + - 114 70 12 6 6 - 97.5 46 26 >1 1 40 3.2 NSY PTB infection 
71 Kanniappan 55 M   O + - 110 70 19 8 5 6 100.2 40 42 <1 1.3 36 2.9 NSY Pt.Sequale Infection 
72 Pandiyan 40 M 108966 ODW - - 130 90 20 10 5 5 97.6 48 40 >1 1.2 78 4 NSY CVT NS 
73 Somasustham 45 M 111215 O + - 120 80 33 12 8 13 101.5 29 26 >1 0.8 78 3.8 
Fatty 
liver 
PN NS 
74 Arumugam 40 M 108904 D + - 120 70 22 10 6 6 95.3 156 100 >1 2.2 80 3.2 
Lt.side 
PE 
Lt.Para 
pnemonic 
effusion 
Infection 
75 Govindan 48 M 111369 O + + 150 100 20 10 5 5 108.7 64 48 >1 2.3 40 3 
Fatty 
liver 
Seizure NS 
76 Rajasekar 50 M 111195 O + - 110 60 32 12 8 12 92.6 402 164 >2 11 179 3.4 
Fatty 
liver 
AH 
Hepato 
billary 
77 Alakesan 63 M 11377 O - - 120 80 24 8 6 10 107.5 62 44 >2 1.8 86 2.5 NSY PTb Infection 
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78 Selvaraj 43 M 116209 C + - 140 90 35 12 10 13 107.5 41 49 <1 4.8 100 3.7 
Fatty 
liver 
Werinkey's 
encephalopathy 
NS 
79 Settu 56 M 116214 O - - 150 100 30 12 8 10 86.9 172 69 >2 1.2 61 3.6 
Fatty 
liver 
AWS NS 
80 Shankar 45 M 116499 O - - 130 80 26 12 6 8 112.8 58 40 >1 2.2 66 3.3 
Fatty 
liver 
AG GIT 
81 Murugan 34 M 86599 D + - 100 70 32 12 8 12 91.6 150 94 >1 0.8 119 3.5 NSY AI NS 
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82 Kumaravel 26 M 116113 D + - 130 80 28 12 8 10 104.5 42 40 >1 1.4 86 3 Fatty liver CAH NS 
83 Dasaradhan 31 M 118758 O + - 120 70 12 4 4 4 97.6 37 39 <1 1 213 3.8 NSY OPC 
Self 
harm 
84 Srinivasan 27 M 110839 O - - 100 70 25 6 9 10 87.5 42 50 <1 1.2 106 3.6 NSY Emphyema Infection 
85 Kesavan 44 M 113828 C + - 160 90 22 7 11 4 104.8 68 32 >2 1.6 86 3.1 
Fatty liver  
Gr.I 
Young 
stroke 
NS 
86 Balachandran 34 M 113550 D + - 100 70 17 6 4 7 106.5 48 71 >1 3.1 126 3.2 DCLD DCLD 
Hepato 
billary 
87 Ashok Kumar 35 M 113912 H - - 100 60 30 10 8 12 110.1 102 73 >3 16.9 96 3 
Fatty liver  
Gr.II 
AH 
Hepato 
billary 
88 Stalin 26 M 115785 C - - 160 90 32 10 10 12 115 51 72 >2 1.3 96 3 Fatty liver CS NS 
89 Nehru 57 M 115904 D + - 140 90 14 6 4 4 106.5 38 71 >1 1.4 102 3.5 NSY 
Bilateral 
thin SDH 
NS 
90 Beliappan 60 M 115884 C - + 120 80 15 6 4 5 83.7 54 36 >1 2.2 55 3.8 Fatty liver CAD CVS 
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91 Mohamed Asan 49 M 1E+06 C - - 130 70 24 8 6 8 109 54 42 >1 1.3 102 3.5 NSY AG GIT 
92 Balamurugan 40 M 116575 O - - 150 90 33 10 9 14 103.1 126 103 >1 1.2 103 3.6 fatty liver PN NS 
93 Gopi 35 M 116492 O - - 130 80 27 12 8 7 102 112 66 >1 1.6 49 3.2 fatty liver AG GIT 
94 Venkattaraman 46 M   C + + 200 120 17 12 5 - 84.4 38 36 >1 1.4 52 2 ↑B/L RE AHT-DM CVS 
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95 Venu 45 M 1E+06 O - - 120 80 24 10 8 6 105.3 40 70 <1 3.4 52 3 Fatty liver AL 
Hepato 
billary 
96 Manikanadan 27 M 109216 O - - 120 80 28 12 6 10 105.4 42 46 <1 1.3 28 3.5 NSY 
attempted  
hanging 
Self 
harm 
97 Narayanasamy 40 M 109177 O - - 110 70 32 10 8 14 108.1 124 69 >1 3.2 46 3.2 Fatty liver AWS NS 
98 Sakthivel 43 M 76707 C + - 140 100 30 12 6 12 102 58 50 >1 1.2 74 3 Fatty liver AG GIT 
99 Sriram 40 M 78788 D + - 130 80 29 10 8 11 106 102 108 >1 1.2 116 3.8 Fatty liver AWS NS 
100 Karunakaran 52 M 795422 O - - 100 60 25 10 7 8 103.2 55 62 <1 2 93 2.9 Fatty liver 
Pyopneumo 
thorax 
Infection 
Abbreviations: 
                      NSY Normal Study CAD Coronary Artery Disease PN Peripheral Neuropathy U Umemployed 
RE Renal Echo NS Nerves System ALD Alcoholic Liver Disease ODW Other Daily wagers 
AWS Alcohol Withdrawal Syndrome GIT Gastero Interstinal System AH Alcoholic Hepatitis O Others 
AG Alcoholic Gastritis DCLD Decompensated Liver Disease SVT Supraventricular Tachycardia 
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AI Alcoholic Intoxication CVT Cerebral Venous Thrombosis D Driver 
AHT Accelerated Hypertension CS Cervical Spondylosis C Construction Workers 
DM Diabetes Mellitus OPC Organophosphorus Compound S Students 
PTb Pulmonary Tuberculosis RVD Retroviral Disease H Hospitality 
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